
Aerozest 0.63mg Respules (2.5 ml each)
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Levosalbutamol (0.63mg)
Overview Aerozest 0.63mg Respules (2.5 ml each)
PulmoEase 0.63mg nebuliser solution (2.5ml vials) is a rapid-acting bronchodilator, relieving symptoms of asthma and chronic obstructive pulmonary disease (COPD). It provides quick relief from wheezing, coughing, and shortness of breath. PulmoEase offers temporary symptom control; most patients will also use a preventative inhaler alongside it. This medication's effects last several hours. Use only when needed—for example, upon symptom onset (cough, wheeze, breathlessness, chest tightness) or before activities triggering breathlessness. During an asthma attack, administer the prescribed dose. Correct inhaler technique is crucial for effectiveness. Discontinue use only under a doctor's guidance; cessation may worsen breathing difficulties. Possible side effects include accidental injury, bronchitis, dizziness, pain, sore throat, pharyngitis, nasal congestion, vomiting, tremors, palpitations, chest pain. Most side effects are mild and transient. Report severe chest pain, intense headache, or severe dizziness immediately. Before starting PulmoEase 0.63mg nebuliser solution (2.5ml vials), inform your doctor of any pre-existing conditions such as hypertension, hyperthyroidism, heart disease, diabetes, or hypokalemia. Disclose pregnancy or breastfeeding. Avoid driving, operating machinery, or cycling if dizziness or shakiness occurs. Smoking exacerbates lung conditions; cessation is strongly advised.
Uses of Aerozest 0.63mg Respules (2.5 ml each)
Asthma and chronic obstructive pulmonary disease (COPD) management
Major Benefits of Aerozest 0.63mg Respules (2.5 ml each):
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Always consult the product label for complete instructions prior to use. Open the respule/transpule by twisting off the cap and completely transfer the contents into the nebulizer for immediate use.
Common Side effects of Aerozest 0.63mg Respules (2.5 ml each):
- Accidental injury
- Bronchitis (inflammation of the airways)
- Dizziness
- Pain
- Pharyngitis
- Nasal congestion (stuffy nose)
- Vomiting
- Chest pain
- Palpitations
- Sore throat
- Tremors
How to use Aerozest 0.63mg Respules (2.5 ml each):
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Always consult the product label for instructions prior to use. Open the respule/transpule by twisting off the cap and completely transfer the contents into the nebulizer for immediate use.
How Aerozest 0.63mg Respules (2.5 ml each) works:
Each 2.5ml Aerozest respule (0.63mg) acts as a bronchodilator, easing breathing by relaxing airway muscles and thus widening the airways.
SAFETY ADVICE
AlcoholUNSAFE
Combining the inhalation solution Aerozest 0.63mg (2.5 ml units) with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Aerozest 0.63mg Respules (2.5 ml each) during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Aerozest 0.63mg Respules (2.5 ml each) while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Aerozest 0.63mg Respules (2.5 ml each) :
Omit any missed Aerozest 0.63mg Respule (2.5ml) and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Aerozest 0.63mg Respules (2.5 ml each)
| Label | Value |
|---|---|
| Chemical Type | Benzyl Alcohol Derivatives |
| Developing Good Habits | No. |
| Treatment Category | Breathing |
| Actions | Short-acting beta-2 agonists |
